Long-term administration of fluoxetine to improve motor recovery after stroke

Future Neurology

Volumn 6, Issue 4, 2011, Pages 455-457

  Berends, Hanneke I ^a   Ijzerman, Maarten J ^a   Movig, Kris Ll ^b   Van Putten, Michel Jam ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

clinical trial; fluoxetine; motor function; neuropharmaca; stroke

Indexed keywords

CITALOPRAM; FLUOXETINE; PLACEBO; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

DRUG ACTIVITY; DRUG TOLERABILITY; HUMAN; LONG TERM CARE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE EXCITABILITY; NOTE; OFF LABEL DRUG USE; PHYSIOTHERAPY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SINGLE DRUG DOSE; STROKE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79960028192     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.11.28     Document Type: Note

References (12)

1. Chollet F Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 10(2), 123-130 (2011).
2. Liepert J, Bauder H, Wolfgang HR, Miltner WH, Taub E, Weiller C. Treatment-induced cortical reorganization after stroke in humans. Stroke 31, 1210-1216 (2000). (Pubitemid 30351235)
3. Chen P, Cohen L, Hallett M. Nervous system reorganization following injury. Neuroscience 111, 761-773 (2002). (Pubitemid 34603248)
4. Berends HI, Nijlant JM, Movig KLL, Van Putten MJAM, Jannink MJA, IJzerman MJ. The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review. Eur. J. Phys. Rehabil. Med. 45(4), 621-630 (2009).
5. Robol E, Fiaschi A, Manganotti P. Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J. Neurol. Sci. 221, 41-46 (2004). (Pubitemid 38724167)
6. Pariente J, Loubinoux, I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 50, 718-729 (2001). (Pubitemid 33116131)
7. Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J. Neurol. 256, 1152-1158 (2009).
8. Gerdelat-Mas A, Loubinoux I, Tombari D, Rascol O, Chollet F, Simonetta-Moreau M. Chronic administration of selective serotonin re-uptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 27, 314-322 (2005). (Pubitemid 41074834)
9. Dam M, Tonin P, De Boni A, Pizzolato G, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27, 1211-1214 (1996). (Pubitemid 26226957)
10. Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil. Neural Repair 22, 311-314 (2008). (Pubitemid 351561669)
11. Berends H, Nijlant J, Movig K, Van Putten M, IJzerman M. Single dose of fluoxetine increases muscle activation in chronic stroke patients. Clin. Neuropharmacol. 32, 1-5 (2009).
12. Loubinoux I, Tombari D, Pariente J, et al. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. Neuroimage 27, 299-313 (2005). (Pubitemid 41074833)